|
P.136 Design of Reach: Phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in FSHD |
|
|
|
Titel: |
P.136 Design of Reach: Phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in FSHD |
Auteur: |
Tawil, R. Han, J. Wang, L. Vissing, J. van Engelen, B. Statland, J. Mellion, M. Shoskes, J. Morabito, C. Jiang, J. Webster, J. |
Verschenen in: |
Neuromuscular disorders |
Paginering: |
Jaargang 32 () nr. S1 pagina's S104 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|